John Lazarchick to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications John Lazarchick has written about Xenograft Model Antitumor Assays.
Connection Strength
0.037
-
Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade. Cancer Lett. 2019 01; 440-441:1-10.
Score: 0.037
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.